You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Bortezomib and thalidomide for the first‑line treatment of multiple myeloma

  • Technology appraisal guidance
  • Reference number: TA228
  • Published:  27 July 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Response to consultee and commentator comments on the economic model

Response to consultee and commentator comments on the economic model Response to consultee and commentator comments on the economic model
17 June 2011
(235.27 Kb 8 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 20 June 2011

Back to top